Spondyloarthropathies News

TNF-inhibitor switching is rare, and delayed by nearly a full year, among patients with ankylosing spondylitis despite a common lack of efficacy, according to data published in BMC Rheumatology.

A review of 75 adalimumab clinical trials in adult and pediatric patients demonstrated low rates of inflammatory bowel disease adverse events, according to data published in Arthritis Care & Research.

The situation with COVID-19, or the currently circulating coronavirus, is developing so rapidly that new information may likely be available by the time you reach the end of this paragraph. But along with factual information, misinformation also abounds on social media, on cable news channels and in print publications. Healio Rheumatology will attempt to set the record straight for health care providers looking to sort out fact from fiction.

Patients with inflammatory rheumatic disease receiving conventional DMARDs and a prime-boost vaccination strategy — a dose of pneumococcal conjugate vaccine and a dose of 23-valent polysaccharide vaccine — saw improved immunogenicity, compared with single pneumococcal conjugate vaccination, according to data published in Arthritis Research & Therapy.

The United Rheumatology Spring National Meeting will offer attendees lectures on cutting edge topics such as genomics and transcriptomics in addition to a range of continuing medical education activities. But the real appeal of United Rheumatology, and of the meeting, will be the guidance that can be provided to independent rheumatologists regarding practice management strategies and interacting with payers.

SCOTTSDALE, Ariz. —Rheumatologists, focused as they are on inflammatory symptoms, are often less familiar with cardiovascular management, according to M. Elaine Husni, MD, MPH, of the Cleveland Clinic.

SCOTTSDALE, Ariz. — IL-23 drives IL-17 production. IL-17 inhibition is effective in ankylosing spondylitis. However, evidence has shown that IL-23 or IL-12/23 inhibition is not necessarily effective in AS.

Approximately 35% of relevant industry payments to U.S.-based authors of American College of Rheumatology clinical practice guidelines remain undisclosed, according to findings published in Arthritis & Rheumatology.

MAUI, Hawaii — Primary care providers and other nonrheumatologists often ordered inappropriate blood tests in patients with suspected inflammatory back pain, according to a presentation at the 2020 Rheumatology Winter Clinical Symposium.

The FDA has approved a label update for secukinumab, allowing the option for a higher 300 mg dose among adults with active ankylosing spondylitis based on clinical response.